The prescribing note should include: the patient's current HbA1c or BMI with date of measurement, a chronological list of all prior therapies with dates and reasons for discontinuation, a statement of why liraglutide specifically is preferred over other non-preferred agents (for example, the cardiovascular outcome benefit documented in LEADER [5] for a patient with known coronary artery disease), and a direct reference to the applicable ADA or Endocrine Society guideline recommendation [6][8]
Anderlini P, Kantarjian, Andreeff M , Kornblau S, O'Brien S, Pierce S, Keating M, Estey E
Increasing feelings of fullness and slowing down gastric emptying, it helps you eat less without feeling constantly hungry
However, the limit to its reuse depends on several factors
Supplementation with high levels of L-carnitine (100-400 mg/kg/day) alleviates most symptoms